Filana Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Filana Therapeutics, Inc. (FLNA) reported Earnings Per Share, Basic and Diluted of -$0.82 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-01
- Filana Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.35.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.24.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.13.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.09.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.82.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.24.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.27.
- Filana Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.61.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.72 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.82 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | -$0.24 10-Q · filed 2021-11-15 | -$0.37 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.46 10-Q · filed 2021-11-15 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-06-30 | -$0.13 10-Q · filed 2021-08-04 | -$0.22 10-Q · filed 2021-08-04 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-03-31 | -$0.09 10-Q · filed 2021-04-29 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.24 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2020-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.24 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | -$0.06 10-Q · filed 2021-11-15 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.15 10-Q · filed 2021-11-15 | -$0.23 derived: net income ÷ weighted average shares · filed 2021-11-15 | ||||
| 2020-06-30 | -$0.05 10-Q · filed 2021-08-04 | -$0.09 10-Q · filed 2021-08-04 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-11-15 | ||||
| 2020-03-31 | -$0.05 10-Q · filed 2021-04-29 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.23 derived: net income ÷ weighted average shares · filed 2021-11-15 | ||||
| 2019-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2021-03-23 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-03-23 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-03-23 | -$0.27 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | -$0.04 10-Q · filed 2020-11-09 | -$0.10 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.18 10-Q · filed 2020-11-09 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-11-09 | ||||
| 2019-06-30 | -$0.06 10-Q · filed 2020-08-12 | -$0.14 10-Q · filed 2020-08-12 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.27 derived: net income ÷ weighted average shares · filed 2020-11-09 | ||||
| 2019-03-31 | -$0.08 10-Q · filed 2020-05-06 | -$0.12 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.43 derived: net income ÷ weighted average shares · filed 2020-11-09 | ||||
| 2018-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.37 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.61 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | -$0.11 10-Q · filed 2019-10-29 | -$0.40 derived: net income ÷ weighted average shares · filed 2019-10-29 | -$0.69 10-Q · filed 2019-10-29 | -$1.04 derived: net income ÷ weighted average shares · filed 2019-10-29 | ||||
| 2018-06-30 | -$0.36 10-Q · filed 2019-08-12 | -$0.68 10-Q · filed 2019-08-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2019-10-29 | -$1.45 derived: net income ÷ weighted average shares · filed 2019-10-29 | ||||
| 2018-03-31 | -$0.33 10-Q · filed 2019-05-02 | -$0.69 derived: net income ÷ weighted average shares · filed 2019-10-29 | -$1.09 derived: net income ÷ weighted average shares · filed 2019-10-29 | -$1.73 derived: net income ÷ weighted average shares · filed 2019-10-29 | ||||
| 2017-12-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$0.77 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$1.40 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$1.82 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | -$0.40 10-Q · filed 2018-10-30 | -$1.03 derived: net income ÷ weighted average shares · filed 2018-10-30 | -$1.45 10-Q · filed 2018-10-30 | -$1.84 derived: net income ÷ weighted average shares · filed 2018-10-30 | ||||
| 2017-06-30 | -$0.64 10-Q · filed 2018-07-26 | -$1.06 10-Q · filed 2018-07-26 | -$1.44 derived: net income ÷ weighted average shares · filed 2018-07-26 | -$1.98 derived: net income ÷ weighted average shares · filed 2018-07-26 | ||||
| 2017-03-31 | -$0.42 10-Q · filed 2018-05-09 | -$0.06 10-Q · filed 2017-04-26 | -$0.81 derived: net income ÷ weighted average shares · filed 2018-05-09 | -$1.34 derived: net income ÷ weighted average shares · filed 2018-05-09 | -$1.81 derived: net income ÷ weighted average shares · filed 2018-05-09 | |||
| 2016-12-31 | -$0.06 10-K · filed 2017-03-07 | -$0.92 derived: net income ÷ weighted average shares · filed 2018-02-06 | -$1.39 derived: net income ÷ weighted average shares · filed 2018-02-06 | -$2.28 10-K · filed 2018-02-06 | -$0.33 10-K · filed 2017-03-07 | |||
| 2016-09-30 | -$0.54 10-Q · filed 2017-11-01 | -$0.08 10-Q · filed 2016-10-26 | -$1.00 derived: net income ÷ weighted average shares · filed 2017-11-01 | -$1.89 10-Q · filed 2017-11-01 | -$0.27 10-Q · filed 2016-10-26 | -$0.65 derived: net income ÷ weighted average shares · filed 2017-11-01 | ||
| 2016-06-30 | -$0.46 10-Q · filed 2017-08-09 | -$0.07 10-Q · filed 2016-07-19 | -$1.35 10-Q · filed 2017-08-09 | -$0.19 10-Q · filed 2016-07-19 | -$0.41 derived: net income ÷ weighted average shares · filed 2017-08-09 | -$0.48 derived: net income ÷ weighted average shares · filed 2017-08-09 | ||
| 2016-03-31 | -$0.13 10-Q · filed 2017-04-26 | -$0.23 derived: net income ÷ weighted average shares · filed 2017-04-26 | -$0.31 derived: net income ÷ weighted average shares · filed 2017-04-26 | -$0.38 derived: net income ÷ weighted average shares · filed 2017-04-26 | ||||
| 2015-12-31 | -$0.10 10-K · filed 2017-03-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.25 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.31 10-K · filed 2017-03-07 | ||||
| 2015-09-30 | -$0.08 10-K · filed 2017-03-07 | -$0.16 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.21 10-Q · filed 2016-10-26 | -$0.26 derived: net income ÷ weighted average shares · filed 2017-03-07 | ||||
| 2015-06-30 | -$0.07 10-K · filed 2017-03-07 | -$0.13 10-Q · filed 2016-07-19 | -$0.18 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.26 derived: net income ÷ weighted average shares · filed 2017-03-07 | ||||
| 2015-03-31 | -$0.06 10-K · filed 2017-03-07 | -$0.10 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.25 derived: net income ÷ weighted average shares · filed 2017-03-07 | ||||
| 2014-12-31 | -$0.05 10-K · filed 2017-03-07 | -$0.13 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.20 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.27 10-K · filed 2017-03-07 | ||||
| 2014-09-30 | -$0.08 10-K · filed 2017-03-07 | -$0.15 derived: net income ÷ weighted average shares · filed 2017-03-07 | -$0.23 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | -$0.07 10-K · filed 2017-03-07 | -$0.15 10-Q · filed 2015-07-23 | ||||||
| 2014-03-31 | -$0.08 10-K · filed 2017-03-07 | |||||||
| 2013-09-30 | -$0.02 10-Q · filed 2014-11-05 | -$0.02 derived: net income ÷ weighted average shares · filed 2014-11-05 | -$0.03 10-Q · filed 2014-11-05 | -$12.58 derived: net income ÷ weighted average shares · filed 2015-02-18 | ||||
| 2013-06-30 | -$0.01 10-Q · filed 2014-08-06 | -$0.02 10-Q · filed 2014-08-06 | $0.17 derived: net income ÷ weighted average shares · filed 2015-02-18 | -$26.93 derived: net income ÷ weighted average shares · filed 2015-02-18 | ||||
| 2013-03-31 | -$0.01 10-Q · filed 2014-05-07 | $0.05 derived: net income ÷ weighted average shares · filed 2015-02-18 | $0.25 derived: net income ÷ weighted average shares · filed 2015-02-18 | -$40.86 derived: net income ÷ weighted average shares · filed 2015-02-18 | ||||
| 2012-12-31 | -$0.04 10-K · filed 2015-02-18 | $0.07 derived: net income ÷ weighted average shares · filed 2015-02-18 | $0.23 derived: net income ÷ weighted average shares · filed 2015-02-18 | -$0.08 10-K · filed 2013-02-08 | ||||
| 2012-09-30 | -$0.03 10-K · filed 2015-02-18 | -$0.04 derived: net income ÷ weighted average shares · filed 2013-11-01 | -$0.04 10-Q · filed 2013-11-01 | |||||
| 2012-06-30 | $0.00 10-K · filed 2015-02-18 | $0.00 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $0.00 10-K · filed 2015-02-18 | |||||||
| 2011-12-31 | -$0.01 10-K · filed 2013-02-08 | -$27.01 derived: net income ÷ weighted average shares · filed 2014-02-05 | -$54.07 derived: net income ÷ weighted average shares · filed 2014-02-05 | -$0.06 10-K · filed 2013-02-08 | ||||
| 2011-09-30 | -$0.02 10-K · filed 2013-02-08 | -$45.37 derived: net income ÷ weighted average shares · filed 2012-11-09 | -$0.05 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | -$0.03 10-K · filed 2013-02-08 | -$0.03 10-Q · filed 2012-08-02 | ||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-08 | |||||||
| 2010-12-31 | -$0.28 10-K · filed 2013-02-08 | |||||||
| 2010-09-30 | -$0.02 10-Q · filed 2011-11-03 | -$0.07 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | -$0.02 10-Q · filed 2011-08-04 | -$0.04 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | -$0.08 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |